| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |